|
Volumn 109, Issue SUPPL. 1, 2001, Pages 77-78
|
Methods to identify and characterize developmental neurotoxicity for human health risk assessment: Overview
|
Author keywords
Developmental neurotoxicity; Neurobiology; Neuropathology; Neuropharmacology; Neurotoxicology
|
Indexed keywords
CHEMICAL AGENT;
TOXIC SUBSTANCE;
AGE;
ANIMAL BEHAVIOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
APOPTOSIS;
ARTICLE;
BRAIN DEVELOPMENT;
BRAIN REGION;
BRAIN WEIGHT;
CELL DIFFERENTIATION;
CELL MIGRATION;
CELL PROLIFERATION;
COGNITION;
DEVELOPMENTAL BIOLOGY;
DEVELOPMENTAL DISORDER;
DOSE RESPONSE;
EXPERIMENTAL ANIMAL;
HEALTH HAZARD;
HISTOLOGY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
MAMMAL;
METHODOLOGY;
MORPHOLOGY;
MYELINATION;
NERVOUS SYSTEM DEVELOPMENT;
NERVOUS SYSTEM FUNCTION;
NERVOUS SYSTEM MALFORMATION;
NEUROANATOMY;
NEUROBIOLOGY;
NEUROPATHOLOGY;
NEUROTOXICITY;
NONHUMAN;
PATHOLOGY;
PERIPHERAL NERVOUS SYSTEM;
PHARMACODYNAMICS;
PHARMACOKINETICS;
PHARMACOLOGY;
PRIORITY JOURNAL;
PROGENY;
QUANTITATIVE ASSAY;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SYNAPTOGENESIS;
TECHNIQUE;
ANIMALIA;
MAMMALIA;
|
EID: 0035047581
PISSN: 00916765
EISSN: None
Source Type: Journal
DOI: 10.1289/ehp.01109s177 Document Type: Article |
Times cited : (18)
|
References (12)
|